Active ingredientGefitinibCat. No. P-G021-001CAS 184475-35-2Family · Pharmaceutical analytical standards
Gefitinib
An oral inhibitor of the EGFR tyrosine kinase that blocks growth signals in cancer cells. First approved in Japan in 2002, it is used in non-small cell lung cancer with EGFR mutations. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?In 2004 several research groups found that patients with dramatic responses had tumours carrying EGFR gene mutations: one of the first examples of a therapy chosen according to the tumour's DNA.
Go to the active ingredient →Active ingredientGefitinibCat. No. P-G021-001CAS 184475-35-2
Pharmacopoeial impurityGefitinib EP Impurity ACat. No. P-G021-002CAS 199327-61-2
Pharmacopoeial impurityGefitinib EP Impurity BCat. No. P-G021-003CAS 1603814-04-5
Pharmacopoeial impurityGefitinib EP Impurity B HClCat. No. P-G021-004
Isotopically labelledGefitinib-d6Cat. No. P-G021-005CAS 1228664-49-0
Isotopically labelledO-Desmethyl Gefitinib-d6Cat. No. P-G021-006
Impurity3-Hydroxy-4-methoxybenzonitrileCat. No. P-G021-007CAS 52805-46-6
Impurity6,7-Dimethoxyquinazolin-4(3H)-oneCat. No. P-G021-008CAS 13794-72-4
Impurity1-Chloro-2-fluoro-3-nitrobenzeneCat. No. P-G021-009CAS 2106-49-2
ImpurityGefitinib Impurity 1Cat. No. P-G021-010CAS 246512-44-7
ImpurityGefitinib IntermediateCat. No. P-G021-011CAS 675126-27-9
Impurity3,4-DifluoroanilineCat. No. P-G021-012CAS 3863-11-4
Impurity3-Chloro-2-fluoroanilineCat. No. P-G021-013CAS 2106-04-9
Impurity3-Chloro-4-fluoroanilineCat. No. P-G021-014CAS 367-21-5
Impurity3-Chloro-4-fluoronitrobenzeneCat. No. P-G021-015CAS 350-30-1
Impurity3-Desmorpholinyl-3-Hydroxyethylamino GefitinibCat. No. P-G021-016CAS 847949-56-8
Impurity3-Hydroxy-4-methoxybenzaldehydeCat. No. P-G021-017CAS 621-59-0
Impurity4,4'-(Propane-1,3-diyl)bismorpholineCat. No. P-G021-018CAS 48152-09-6
ImpurityGefitinib Impurity 2Cat. No. P-G021-019CAS 788136-89-0
Impurity4-(3-Chloropropyl)morpholineCat. No. P-G021-020CAS 7357-67-7
Impurity4-(3-Chloropropyl)morpholine HydrochlorideCat. No. P-G021-021CAS 57616-74-7
ImpurityGefitinib Impurity 3Cat. No. P-G021-022CAS 692059-41-9
ImpurityGefitinib Impurity 4Cat. No. P-G021-023CAS 199327-59-8
Impurity4-chloro-7-methoxyquinazolin-6-ylacetateCat. No. P-G021-024CAS 230955-75-6
Impurity4-Defluoro-4-Hydroxy GefitinibCat. No. P-G021-025CAS 847949-50-2
ImpurityGefitinib Impurity 5Cat. No. P-G021-026CAS 675126-28-0
ImpurityGefitinib Impurity 6Cat. No. P-G021-027CAS 861453-11-4
ImpurityGefitinib Impurity 7Cat. No. P-G021-028CAS 861453-12-5
ImpurityGefitinib Impurity 8Cat. No. P-G021-029CAS 861453-16-9
ImpurityGefitinib Impurity 9Cat. No. P-G021-030CAS 675126-26-8
Impurity5-Hydroxy-4-methoxy-2-nitrobenzonitrileCat. No. P-G021-031CAS 1379208-77-1
ImpurityGefitinib Impurity 10Cat. No. P-G021-032CAS 193552-54-4
ImpurityGefitinib Impurity 11Cat. No. P-G021-033CAS 179688-53-0
Impurity6-Hydroxy-7-methoxy-4(1H)-quinazolinoneCat. No. P-G021-034CAS 179688-52-9
ImpurityGefitinib 3,4-Difluoro Impurity DiHClCat. No. P-G021-035
ImpurityGefitinib 3,4-Difluoro Impurity HClCat. No. P-G021-036CAS 184475-68-1
ImpurityGefitinib 4-Desfluoro Impurity HClCat. No. P-G021-037
ImpurityGefitinib Impurity 12Cat. No. P-G021-038
ImpurityGefitinib Impurity 12 DihydrochlorideCat. No. P-G021-039
ImpurityGefitinib Impurity 13Cat. No. P-G021-040
ImpurityGefitinib Impurity 14Cat. No. P-G021-041
ImpurityGefitinib Impurity 15Cat. No. P-G021-042
ImpurityGefitinib Impurity 16Cat. No. P-G021-043
ImpurityGefitinib Impurity 17Cat. No. P-G021-044
ImpurityGefitinib Impurity 18Cat. No. P-G021-045
ImpurityGefitinib Impurity 19Cat. No. P-G021-046
ImpurityGefitinib Impurity 20Cat. No. P-G021-047
ImpurityGefitinib Impurity 21Cat. No. P-G021-048
ImpurityGefitinib Impurity 22Cat. No. P-G021-049
ImpurityGefitinib Impurity 23Cat. No. P-G021-050
ImpurityGefitinib Impurity 24Cat. No. P-G021-051
ImpurityGefitinib Impurity 25Cat. No. P-G021-052
ImpurityGefitinib Impurity 26Cat. No. P-G021-053
ImpurityGefitinib Impurity 27Cat. No. P-G021-054
ImpurityGefitinib Impurity 28Cat. No. P-G021-055
ImpurityGefitinib Impurity 29Cat. No. P-G021-056
ImpurityGefitinib Impurity 30Cat. No. P-G021-057
ImpurityGefitinib Impurity 31Cat. No. P-G021-058
ImpurityGefitinib Impurity 32Cat. No. P-G021-059
ImpurityGefitinib Impurity 33Cat. No. P-G021-060CAS 1374224-08-4
ImpurityGefitinib Impurity 34Cat. No. P-G021-061CAS 2347417-64-3
ImpurityGefitinib Impurity 35Cat. No. P-G021-062CAS 912556-91-3
ImpurityGefitinib Impurity 36Cat. No. P-G021-063CAS 847949-54-6
ImpurityGefitinib Impurity 37Cat. No. P-G021-064
ImpurityGefitinib Impurity 38 HydrochlorideCat. No. P-G021-066
ImpurityGefitinib Impurity 39Cat. No. P-G021-067
ImpurityGefitinib Impurity 40Cat. No. P-G021-068
ImpurityGefitinib Impurity 41Cat. No. P-G021-069
ImpurityGefitinib Impurity 42Cat. No. P-G021-070CAS 950596-57-3
ImpurityGefitinib Impurity 43Cat. No. P-G021-071CAS 610798-32-8
ImpurityGefitinib Impurity 44Cat. No. P-G021-072
ImpurityGefitinib Impurity 45Cat. No. P-G021-073
ImpurityGefitinib Impurity 46Cat. No. P-G021-074CAS 1608115-59-8
ImpurityGefitinib Impurity 47Cat. No. P-G021-075CAS 95-76-1
ImpurityGefitinib N-OxideCat. No. P-G021-077CAS 847949-51-3
ImpurityGefitinib Impurity 48Cat. No. P-G021-078CAS 194423-17-1
ImpurityN-(3-Morpholinopropyl) GefitinibCat. No. P-G021-079CAS 1502829-45-9
ImpurityN-(3-Morpholinopropyl) Gefitinib TriHClCat. No. P-G021-080
ImpurityO-Desmethyl GefitinibCat. No. P-G021-081CAS 847949-49-9
ImpurityO-Desmorpholinopropyl GefitinibCat. No. P-G021-082CAS 184475-71-6
ImpurityO-Desmorpholinopropyl-O-methyl-gefitinibCat. No. P-G021-083CAS 153437-78-6No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceGefitinib CRSEDQM code Y0001813Family GefitinibNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.